BOSHOFF
Chris
Chief Development Officer, Oncology and Rare Disease, Pfizer
Organization: Pfizer
Profession: Chief Development Officer
Biography
Career
Chris Boshoff, FRCP, FMedSci, PhD, is the Chief Development Officer for Oncology at Pfizer where he is responsible for overseeing clinical research and development activities for all promising cancer medicines. Formerly he was the Head and Senior Vice President for Immuno-Oncology, Early Development and Translational Oncology, directing strategies for early cancer drug development, precision medicine and immuno-oncology.
Education
Dr Boshoff obtained his PhD from the Institute of Cancer Research in London and trained as a medical oncologist at the Royal Marsden and Royal Free Hospitals in London. Before joining Pfizer in 2013, he was the Director of the University College London (UCL) Cancer Institute (2007-2013). He was appointed Adjunct Professor at Yale University in 2014, and has published more than 150 original articles covering cancer biology, tumor virology, and experimental cancer medicine.
Rating GlobalNY.biz
Mention in the company news
Mentioned together
Colleagues
Profile statistic
